| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| prostaglandin-endoperoxide synthase 2 |
CLOSANTEL |
Cyclooxygenase COX-2 |
78% |
1.839uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
CLOSANTEL |
Cyclooxygenase COX-2 |
78% |
1.839uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 4 polypeptide |
CLOSANTEL |
ATPase, Na+/K+ |
78% |
4.875uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 3 polypeptide |
CLOSANTEL |
ATPase, Na+/K+ |
78% |
4.875uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
CLOSANTEL |
ATPase, Na+/K+ |
78% |
4.875uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
CLOSANTEL |
ATPase, Na+/K+ |
78% |
4.875uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
CLOSANTEL |
ATPase, Na+/K+ |
78% |
4.875uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 3 polypeptide |
CLOSANTEL |
ATPase, Na+/K+ |
78% |
4.875uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 2 polypeptide |
CLOSANTEL |
ATPase, Na+/K+ |
78% |
4.875uM |
NoneNone |
View
|
| ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
CLOSANTEL |
ATPase, Na+/K+ |
78% |
4.875uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
BENZTROPINE |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.348uM |
1.311uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
BENZTROPINE |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.348uM |
1.311uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
BENZTROPINE |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.348uM |
1.311uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
BENZTROPINE |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.348uM |
1.311uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
BENZTROPINE |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.348uM |
1.311uM |
View
|
| Cytochrom P450-2C19 monooxygenase |
DIHYDROERGOCRISTINE MESYLATE |
CYP450-2C19 Inhibition |
77% |
3uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
LISURIDE |
Calcium Channel Type L, Phenylalkylamine |
77% |
1.436uM |
1.396uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
PROMAZINE |
Calcium Channel Type L, Benzothiazepine |
77% |
3.217uM |
2.86uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
PROMAZINE |
Calcium Channel Type L, Benzothiazepine |
77% |
3.217uM |
2.86uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
PROMAZINE |
Calcium Channel Type L, Benzothiazepine |
77% |
3.217uM |
2.86uM |
View
|
| adrenergic, beta-1-, receptor |
ATENOLOL |
Adrenergic beta1 |
76% |
1.313uM |
.758uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
DIMENHYDRINATE |
Adrenergic, Norepinephrine Transporter |
76% |
2.037uM |
2.02uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
7.28uM |
7.078uM |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
MAPROTILINE |
Sodium Channel, Site 2 |
76% |
2.572uM |
2.346uM |
View
|
| sodium channel, voltage-gated, type I, beta |
MAPROTILINE |
Sodium Channel, Site 2 |
76% |
2.572uM |
2.346uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
MAPROTILINE |
Sodium Channel, Site 2 |
76% |
2.572uM |
2.346uM |
View
|
| histamine receptor H 2 |
LISURIDE |
Histamine H2 |
76% |
1.04uM |
1.022uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
BUTENAFINE |
Adrenergic, Norepinephrine Transporter |
76% |
3.9099uM |
3.8775uM |
View
|
| Sigma-2 Receptor |
QUETIAPINE |
Sigma2 |
76% |
1.8851uM |
1.1601uM |
View
|
| cholinergic receptor, muscarinic 4 |
TERCONAZOLE |
Muscarinic M4 |
76% |
13.714uM |
1.913uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
PAROXETINE |
Calcium Channel Type L, Phenylalkylamine |
76% |
.747uM |
.726uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOMIPHENE |
Calcium Channel Type L, Dihydropyridine |
75% |
1.62uM |
1.041uM |
View
|
| adrenergic receptor, alpha 2a |
CADMIUM ACETATE |
Adrenergic alpha2A |
75% |
4.556uM |
1.709uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
RILUZOLE |
Adrenergic, Norepinephrine Transporter |
75% |
1.733uM |
1.718uM |
View
|
| adrenergic receptor, alpha 2a |
DROPERIDOL |
Adrenergic alpha2A |
75% |
2.965uM |
1.112uM |
View
|
| adrenergic receptor, alpha 1b |
EMETINE |
Adrenergic alpha1B |
75% |
1.934uM |
1.071uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| adrenergic, beta-1-, receptor |
SOTALOL |
Adrenergic beta1 |
73% |
1.4434uM |
.8335uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
EMETINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.356uM |
2.094uM |
View
|
| chemokine (C-C motif) receptor 4 |
DISULFIRAM |
Chemokine CCR4 |
75% |
8.395uM |
4.397uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
SIBUTRAMINE |
Calcium Channel Type L, Benzothiazepine |
75% |
.809uM |
.719uM |
View
|
| dopamine receptor 2 |
TERFENADINE |
Dopamine D2L |
75% |
6.167uM |
2.056uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CYCLIZINE |
Calcium Channel Type L, Benzothiazepine |
75% |
2.518uM |
2.239uM |
View
|
| Cytochrom P450-2D6 monooxygenase |
IDEBENONE |
CYP450-2D6 Inhibition |
75% |
3uM |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
MEGESTROL ACETATE |
CYP450-2C9 Inhibition |
75% |
10uM |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
MEGESTROL ACETATE |
CYP450-2C9 Inhibition |
75% |
10uM |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Protein Serine/Threonine Kinase, p38alpha |
75% |
2.176uM |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Protein Serine/Threonine Kinase, p38alpha |
75% |
2.176uM |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
CLOSANTEL |
Protein Serine/Threonine Kinase, ERK2 |
75% |
1.428uM |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
CLOSANTEL |
Protein Serine/Threonine Kinase, ERK2 |
75% |
1.428uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1a |
KITASAMYCIN |
Adrenergic alpha1A |
75% |
1.544uM |
.625uM |
View
|
| 5-hydroxytryptamine receptor 6 |
BENZTROPINE |
Serotonin 5-HT6 |
75% |
2.788uM |
1.294uM |
View
|
| adrenergic receptor, beta 1 |
DOBUTAMINE |
Adrenergic beta1 |
75% |
1.944uM |
1.123uM |
View
|
| adrenergic, beta-1-, receptor |
DOBUTAMINE |
Adrenergic beta1 |
75% |
1.944uM |
1.123uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
QUETIAPINE |
Serotonin 5-HT2C |
75% |
3.3008uM |
1.729uM |
View
|
| opioid receptor, sigma 1 |
PYRILAMINE |
Sigma1 |
75% |
1.558uM |
.655uM |
View
|
| matrix metallopeptidase 9 |
SECOBARBITAL |
Protease, Matrix Metalloprotease-9 (MMP-9) |
75% |
2.643uM |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
SECOBARBITAL |
Protease, Matrix Metalloprotease-9 (MMP-9) |
75% |
2.643uM |
NoneNone |
View
|
| adrenergic receptor, beta 3 |
GW-1929 |
Adrenergic beta3 |
75% |
22.08uM |
16.564uM |
View
|
| dopamine receptor 2 |
DIETHYLSTILBESTROL |
Dopamine D2L |
75% |
13.321uM |
4.44uM |
View
|
| Cytochrom P450-2C19 monooxygenase |
MEDROXYPROGESTERONE |
CYP450-2C19 Inhibition |
75% |
2uM |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
FLUTAMIDE |
Serotonin 5-HT6 |
75% |
17.814uM |
8.271uM |
View
|
| 5-hydroxytryptamine receptor 6 |
BISPHENOL A |
Serotonin 5-HT6 |
75% |
5.42uM |
2.516uM |
View
|
| thromboxane A synthase 1 |
ALPHA-NAPHTHOFLAVONE |
Thromboxane Synthetase |
75% |
6.7608uM |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
ALPHA-NAPHTHOFLAVONE |
Thromboxane Synthetase |
75% |
6.7608uM |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
DOXORUBICIN |
Sodium Channel, Site 2 |
75% |
15.245uM |
13.668uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
SERTRALINE |
Calcium Channel Type L, Benzothiazepine |
74% |
1.468uM |
1.3049uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
SERTRALINE |
Calcium Channel Type L, Benzothiazepine |
74% |
1.468uM |
1.3049uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
SERTRALINE |
Calcium Channel Type L, Benzothiazepine |
74% |
1.468uM |
1.3049uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
SERTRALINE |
Calcium Channel Type L, Benzothiazepine |
74% |
1.468uM |
1.3049uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
SERTRALINE |
Calcium Channel Type L, Benzothiazepine |
74% |
1.468uM |
1.3049uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
SERTRALINE |
Calcium Channel Type L, Benzothiazepine |
74% |
1.468uM |
1.3049uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
BENZTROPINE |
Calcium Channel Type L, Phenylalkylamine |
78% |
1.348uM |
1.311uM |
View
|
| androgen receptor |
DIELDRIN |
Testosterone |
77% |
6.885uM |
4.59uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
PROPRANOLOL |
Serotonin 5-HT2C |
77% |
2.294uM |
1.202uM |
View
|
| cholinergic receptor, muscarinic 2 |
SERTRALINE |
Muscarinic M2 |
77% |
2.7675uM |
.984uM |
View
|
| opioid receptor, delta 1 |
NALBUPHINE |
Opiate delta |
77% |
1.886uM |
.665uM |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
NIMODIPINE |
CYP450-2C9 Inhibition |
77% |
1uM |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
NIMODIPINE |
CYP450-2C9 Inhibition |
77% |
1uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
ORPHENADRINE |
Adrenergic alpha2B |
77% |
1.895uM |
.865uM |
View
|
| dopamine receptor D3 |
LACIDIPINE |
Dopamine D3 |
77% |
6.17uM |
2.096uM |
View
|
| adrenergic receptor, alpha 2b |
RALOXIFENE |
Adrenergic alpha2C |
77% |
.738uM |
.107uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
RALOXIFENE |
Adrenergic alpha2C |
77% |
.738uM |
.107uM |
View
|
| adrenergic receptor, beta 3 |
CLOMIPHENE |
Adrenergic beta3 |
77% |
5.673uM |
4.254uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
VENLAFAXINE |
Adrenergic, Norepinephrine Transporter |
77% |
2.708uM |
2.685uM |
View
|
| cholinergic receptor, muscarinic 2 |
CLOMIPHENE |
Muscarinic M2 |
77% |
3.628uM |
1.29uM |
View
|
| Sigma-2 Receptor |
DROPERIDOL |
Sigma2 |
77% |
3.283uM |
2.02uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
DIPHENHYDRAMINE |
Serotonin 5-HT2B |
77% |
1.118uM |
.711uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
DIPHENHYDRAMINE |
Adrenergic, Norepinephrine Transporter |
77% |
3.542uM |
3.513uM |
View
|
| Cytochrom P450-1A2 monooxygenase |
DISULFIRAM |
CYP450-1A2 Inhibition |
77% |
4uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
TAMOXIFEN |
Adrenergic alpha1D |
77% |
4.982uM |
2.449uM |
View
|
| adrenergic receptor, alpha 2a |
ERGONOVINE |
Imidazoline I2, Central |
77% |
1.843uM |
1.228uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
ERGONOVINE |
Imidazoline I2, Central |
77% |
1.843uM |
1.228uM |
View
|
| dopamine receptor D1A |
ERGONOVINE |
Dopamine D1 |
77% |
5.901uM |
2.95uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
CLEMASTINE |
Adrenergic, Norepinephrine Transporter |
77% |
3.086uM |
3.06uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
CLOZAPINE |
Adrenergic, Norepinephrine Transporter |
77% |
1.47uM |
1.458uM |
View
|
| leukotriene B4 receptor 2 |
BENZOTHIAZYL DISULFIDE |
Leukotriene B4 |
77% |
5.1uM |
1.3uM |
View
|
| leukotriene B4 receptor |
BENZOTHIAZYL DISULFIDE |
Leukotriene B4 |
77% |
5.1uM |
1.3uM |
View
|
| leukotriene B4 receptor |
BENZOTHIAZYL DISULFIDE |
Leukotriene B4 |
77% |
5.1uM |
1.3uM |
View
|
| leukotriene B4 receptor 2 |
BENZOTHIAZYL DISULFIDE |
Leukotriene B4 |
77% |
5.1uM |
1.3uM |
View
|
| cholinergic receptor, muscarinic 1 |
FLUOXETINE |
Muscarinic M1 |
77% |
3.203uM |
.771uM |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
DEXTROMETHORPHAN |
Glutamate, NMDA, Phencyclidine |
77% |
2.415uM |
1.636uM |
View
|
| glutamate receptor, ionotropic, NMDA2C |
DEXTROMETHORPHAN |
Glutamate, NMDA, Phencyclidine |
77% |
2.415uM |
1.636uM |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
DEXTROMETHORPHAN |
Glutamate, NMDA, Phencyclidine |
77% |
2.415uM |
1.636uM |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
DEXTROMETHORPHAN |
Glutamate, NMDA, Phencyclidine |
77% |
2.415uM |
1.636uM |
View
|
| N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
DEXTROMETHORPHAN |
Glutamate, NMDA, Phencyclidine |
77% |
2.415uM |
1.636uM |
View
|
| glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
DEXTROMETHORPHAN |
Glutamate, NMDA, Phencyclidine |
77% |
2.415uM |
1.636uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
IPRIFLAVONE |
Adrenergic, Norepinephrine Transporter |
77% |
2.5125uM |
2.4917uM |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
S(-)-CARBIDOPA |
Protein Tyrosine Kinase, Lck |
77% |
6.795uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
TRAZODONE |
Imidazoline I2, Central |
77% |
2.891uM |
1.927uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
TRAZODONE |
Imidazoline I2, Central |
77% |
2.891uM |
1.927uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
TRAZODONE |
Serotonin 5-HT1B |
77% |
1.356uM |
.83uM |
View
|
| cholinergic receptor, muscarinic 3 |
GENTIAN VIOLET |
Muscarinic M3 |
77% |
4.33uM |
.918uM |
View
|
